Bingham Osborn & Scarborough’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $418K | Buy |
|
|||||
|
2021
Q2 | $453K | Buy |
|
|||||
|
2021
Q1 | $427K | Buy |
|
|||||
|
2020
Q4 | $395K | Sell |
|
|||||
|
2020
Q3 | $388K | Buy |
|
|||||
|
2020
Q2 | $372K | Sell |
|
|||||
|
2020
Q1 | $361K | Buy |
|
|||||
|
2019
Q4 | $387K | Buy |
|
|||||
|
2019
Q3 | $282K | Sell |
|
|||||
|
2019
Q2 | $264K | Buy |
|
|||||
|
2019
Q1 | $212K | Buy |
|
|||||
|
2018
Q4 | $229K | Sell |
|
|||||
|
2018
Q3 | $380K | Buy |
|
|||||
|
2018
Q2 | $297K | Sell |
|
|||||
|
2018
Q1 | $341K | Buy |
|
|||||
|
2017
Q4 | $326K | Sell |
|
|||||
|
2017
Q3 | $534K | Buy |
|
|||||
|
2017
Q2 | $459K | Sell |
|
|||||
|
2017
Q1 | $510K | Buy |
|
|||||
|
2016
Q4 | $462K | Buy |
|
|||||
|
2016
Q3 | $419K | Sell |
|
|||||
|
2016
Q2 | $611K | Buy |
|
|||||
|
2016
Q1 | $525K | Buy |
|
|||||
|
2015
Q4 | $521K | Sell |
|
|||||
|
2015
Q3 | $540K | Buy |
|
|||||
|
2015
Q2 | $588K | Buy |
|
|||||
|
2015
Q1 | $565K | Sell |
|
|||||
|
2014
Q4 | $557K | Buy |
|
|||||
|
2014
Q3 | $475K | Sell |
|
|||||
|
2014
Q2 | $469K | Sell |
|
|||||
|
2014
Q1 | $527K | Hold |
|
|||||
|
2013
Q4 | $539K | Buy |
|
|||||
|
2013
Q3 | $395K | Buy |
|
|||||
|
2013
Q2 | $290K | Buy |
|